Table 2 Policy areas, technologies and research topic areas
Number | % Total | |
|---|---|---|
Health policy areas for HTA (important or very important)a | ||
Registration of individual health technologies | 26 | 65% |
Reimbursement of individual health technologies | 37 | 93% |
Clinical guidelines or disease management pathways development | 33 | 83% |
Design of basic package of health benefits | 38 | 93% |
Service delivery for health | 34 | 85% |
Reform of provider payment systems | 34 | 85% |
Health technologies for HTA (important or very important)a | ||
Medicines | 34 | 85% |
Vaccines | 35 | 90% |
Medical devices | 40 | 98% |
Screening programmes | 36 | 92% |
Referral programmes | 30 | 75% |
Procedures by health professionals (e.g. surgeries) | 33 | 83% |
Public health programmes or initiatives | 34 | 89% |
Service delivery initiatives or incentives | 30 | 83% |
Topics proposed by respondents | ||
Diagnostics | 6 | 15% |
Drugs and devices | 4 | 10% |
Health promotion and disease prevention | 13 | 33% |
Health services | 4 | 10% |
Service delivery | 8 | 20% |
Other | 5 | 13% |
Total | 40 | 100% |